| Literature DB >> 28533921 |
Mustafa Kaplan1, Ihsan Ates1, Mahmut Yuksel1, Yasemin Ozderin Ozin1, Murat Alisik1, Ozcan Erel1, Ertugrul Kayacetin1.
Abstract
AIM: To determine dynamic thiol/disulphide homeostasis in celiac disease and to examine the associate with celiac autoantibodies and gluten-free diet.Entities:
Keywords: Anti-gliadin antibodies; Anti-tissue transglutaminase antibody; Gluten-free diet; Oxidative stress; Thiol oxidation
Year: 2017 PMID: 28533921 PMCID: PMC5421110 DOI: 10.4292/wjgpt.v8.i2.120
Source DB: PubMed Journal: World J Gastrointest Pharmacol Ther ISSN: 2150-5349
Demographic characteristics and laboratory findings of study population
| Gender (male), | 15 (20.5) | 18 (24.7) | 0.553 |
| Age (yr) | 44.1 ± 13 | 43.7 ± 13.6 | 0.866 |
| BMI (kg/m2) | 24.5 ± 4.7 | 24.9 ± 4.7 | 0.867 |
| Smoking, | |||
| Non-smokers | 49 (67.1) | 50 (68.5) | |
| Smokers | 18 (24.7) | 17 (23.3) | 0.981 |
| Quit smoking | 6 (8.2) | 6 (8.2) | |
| Alcohol, | 2 (2.7) | - | - |
| Duration of disease (yr) | 6 (1-25) | - | - |
| Total protein (g/L) | 7.4 ± 0.6 | 7.4 ± 0.5 | 0.964 |
| Albumin (g/L) | 4.4 ± 0.3 | 4.1 ± 0.3 | 0.002 |
| ALT (IU/L) | 23 (8) | 20 (7) | 0.035 |
| AST (IU/L) | 20 (12) | 17 (9) | 0.002 |
| CRP (mg/L) | 3.5 (8.4) | 1.2 (2) | 0.008 |
| Native thiol (μmol/L) | 322.7 ± 39.7 | 339.6 ± 51.3 | 0.027 |
| Total thiol (μmol/L) | 343.7 ± 41.9 | 360.4 ± 50.3 | 0.031 |
| Disulphide (μmol/L) | 13.0 ± 3.7 | 10.2 ± 3.9 | < 0.001 |
| Disulphide/native thiol (%) | 3.8 ± 1.2 | 2.8 ± 1.1 | < 0.001 |
| Disulphide/total thiol (%) | 4.1 ± 1.4 | 2.9 ± 1.1 | < 0.001 |
| Native thiol/total thiol (%) | 93.8 ± 2.6 | 94.3 ± 5.7 | 0.553 |
P < 0.05. BMI: Body mass index; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; CRP: C-reactive protein.
Dietary compliance of native thiol, disulphide and disulphide/native thiol and its distribution regarding antibody positivity
| Diet | ||||||
| GCD ( | 310.6 ± 46.8 | 0.013 | 13.8 ± 3.2 | 0.034 | 5.2 ± 1.4 | < 0.001 |
| GFD ( | 327.9 ± 35.6 | 12.0 ± 3.3 | 3.5 ± 1.7 | |||
| AGA-IgA | ||||||
| (-) ( | 310.5 ± 39.5 | 0.015 | 14.1 ± 3.7 | 0.020 | 4.7 ± 1.9 | 0.005 |
| (+) ( | 333.8 ± 40.1 | 12.0 ± 3.8 | 3.6 ± 1.4 | |||
| AGA-IgG | ||||||
| (-) ( | 308.5 ± 36.8 | 0.027 | 13.9 ± 3.1 | 0.001 | 4.6 ± 1.7 | < 0.001 |
| (+) ( | 330.5 ± 45.2 | 11.1 ± 3.9 | 3.0 ± 1.1 | |||
| Anti-t TGA | ||||||
| (-) ( | 315.5 ± 38.2 | 0.001 | 13.9 ± 3.9 | 0.019 | 4.5 ± 1.9 | 0.007 |
| (+) ( | 346.2 ± 40.5 | 11.7 ± 3.8 | 3.4 ± 1.5 | |||
| Anti-t TGG | ||||||
| (-) ( | 318.1 ± 37.6 | 0.002 | 13.5 ± 3.9 | 0.009 | 0.035 | |
| (+) ( | 345.3 ± 51.5 | 10.3 ± 3.0 |
P < 0.05. GCD: Gluten-containing diet; GFD: Gluten-free diet; AGA-IgA: Anti gliadin antibodies IgA; AGA-IgG: Anti gliadin antibodies IgG; Anti-t TGA: Anti-tissue Transglutaminase IgA antibodies; Anti-t TGG: Anti-tissue Transglutaminase IgA antibodies.
Findings related to thiol/disulphide hemostasis parameters in celiac patient group
| Age | 0.261 | 0.026 | 0.262 | 0.025 | -0.041 | 0.729 | -0.132 | 0.264 | -0.122 | 0.302 | 0.021 | 0.861 |
| BMI | 0.19 | 0.107 | 0.187 | 0.114 | -0.033 | 0.783 | -0.096 | 0.421 | -0.113 | 0.34 | 0.045 | 0.702 |
| Total protein | -0.032 | 0.786 | 0.005 | 0.97 | 0.059 | 0.618 | 0.032 | 0.787 | 0.086 | 0.472 | -0.156 | 0.187 |
| Albumin | 0.009 | 0.937 | 0.025 | 0.835 | -0.037 | 0.754 | -0.065 | 0.582 | -0.040 | 0.735 | -0.071 | 0.548 |
| AST | 0.051 | 0.666 | 0.046 | 0.702 | -0.03 | 0.801 | -0.057 | 0.631 | -0.031 | 0.796 | 0.033 | 0.781 |
| ALT | -0.091 | 0.444 | -0.116 | 0.329 | -0.063 | 0.598 | -0.012 | 0.919 | 0.002 | 0.985 | 0.094 | 0.427 |
| CRP | -0.327 | 0.018 | -0.304 | 0.038 | 0.369 | 0.015 | 0.287 | 0.043 | 0.332 | 0.029 | -0.244 | 0.038 |
| AGA-IgA | -0.325 | 0.009 | -0.266 | 0.035 | 0.384 | 0.024 | 0.324 | 0.010 | 0.325 | 0.009 | -0.266 | 0.035 |
| AGA-IgG | -0.332 | 0.008 | -0.271 | 0.022 | 0.298 | 0.010 | 0.297 | 0.011 | 0.253 | 0.031 | -0.279 | 0.017 |
| Anti-t TGA | -0.342 | 0.007 | -0.28 | 0.017 | 0.305 | 0.009 | 0.311 | 0.004 | 0.280 | 0.035 | -0.294 | 0.028 |
| Anti-t TGG | -0.35 | 0.00 | -0.316 | 0.004 | 0.315 | 0.007 | 0.34 | 0.001 | 0.302 | 0.014 | -0.304 | 0.019 |
| AGA-IgA | -0.313 | 0.006 | -0.301 | 0.026 | 0.334 | 0.004 | 0.353 | < 0.001 | 0.315 | 0.011 | -0.319 | 0.013 |
| AGA-IgG | -0.335 | 0.004 | -0.324 | 0.005 | 0.309 | 0.018 | 0.366 | 0.023 | 0.349 | 0.033 | -0.288 | 0.045 |
| Anti-t TGA | -0.261 | 0.043 | -0.243 | 0.035 | 0.376 | 0.036 | 0.322 | 0.011 | 0.335 | 0.009 | -0.273 | 0.038 |
| Anti-t TGG | -0.333 | 0.032 | -0.282 | 0.037 | 0.294 | 0.031 | 0.305 | 0.026 | 0.336 | 0.036 | -0.314 | 0.013 |
P < 0.05.
Demographic characteristics and laboratory parameters are adjusted. BMI: Body mass index; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; CRP: C-reactive protein; AGA-IgA: Anti gliadin antibodies IgA; AGA-IgG: Anti gliadin antibodies IgG; Anti-t TGA: Anti-tissue Transglutaminase IgA antibodies; Anti-t TGG: Anti-tissue Transglutaminase IgA antibodies.